PT Indofarma Persero, Tbk announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was IDR 1,590,000.000 million compared to IDR 1,630,000.000 million a year ago. Operating income was IDR 25,910.150 million compared to operating loss of IDR 4,282.682 million a year ago. Net loss was IDR 32,735.901 million compared to IDR 46,282.940 million a year ago. Basic loss per share was IDR 10.56 compared to IDR 14.93 a year ago.